Logo image of ALESE.PA

ENTECH SACA (ALESE.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALESE - FR0014004362 - Common Stock

7.95 EUR
-0.06 (-0.75%)
Last: 11/27/2025, 7:00:00 PM
Fundamental Rating

4

Overall ALESE gets a fundamental rating of 4 out of 10. We evaluated ALESE against 44 industry peers in the Construction & Engineering industry. While ALESE seems to be doing ok healthwise, there are quite some concerns on its profitability. ALESE is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ALESE has reported negative net income.
In the past year ALESE had a positive cash flow from operations.
ALESE had negative earnings in 4 of the past 5 years.
In the past 5 years ALESE always reported negative operating cash flow.
ALESE.PA Yearly Net Income VS EBIT VS OCF VS FCFALESE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -2M -4M -6M -8M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -3.88%, ALESE is doing worse than 90.91% of the companies in the same industry.
With a Return On Equity value of -11.31%, ALESE is not doing good in the industry: 86.36% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -3.88%
ROE -11.31%
ROIC N/A
ROA(3y)-2.34%
ROA(5y)-0.87%
ROE(3y)-4.85%
ROE(5y)-2.97%
ROIC(3y)N/A
ROIC(5y)N/A
ALESE.PA Yearly ROA, ROE, ROICALESE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

ALESE's Gross Margin of 42.82% is in line compared to the rest of the industry. ALESE outperforms 56.82% of its industry peers.
ALESE's Gross Margin has declined in the last couple of years.
ALESE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.07%
GM growth 5YN/A
ALESE.PA Yearly Profit, Operating, Gross MarginsALESE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 40 60

6

2. Health

2.1 Basic Checks

ALESE does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALESE has about the same amout of shares outstanding than it did 1 year ago.
ALESE has a worse debt/assets ratio than last year.
ALESE.PA Yearly Shares OutstandingALESE.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M
ALESE.PA Yearly Total Debt VS Total AssetsALESE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 2.26 indicates that ALESE is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.26, ALESE is in the better half of the industry, outperforming 68.18% of the companies in the same industry.
The Debt to FCF ratio of ALESE is 1.80, which is an excellent value as it means it would take ALESE, only 1.80 years of fcf income to pay off all of its debts.
ALESE's Debt to FCF ratio of 1.80 is fine compared to the rest of the industry. ALESE outperforms 75.00% of its industry peers.
ALESE has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.27, ALESE is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 1.8
Altman-Z 2.26
ROIC/WACCN/A
WACC7.68%
ALESE.PA Yearly LT Debt VS Equity VS FCFALESE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 1.57 indicates that ALESE should not have too much problems paying its short term obligations.
ALESE has a better Current ratio (1.57) than 81.82% of its industry peers.
ALESE has a Quick Ratio of 1.51. This is a normal value and indicates that ALESE is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ALESE (1.51) is better than 88.64% of its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.51
ALESE.PA Yearly Current Assets VS Current LiabilitesALESE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

7

3. Growth

3.1 Past

The earnings per share for ALESE have decreased strongly by -294.30% in the last year.
ALESE shows a strong growth in Revenue. In the last year, the Revenue has grown by 32.45%.
ALESE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 68.95% yearly.
EPS 1Y (TTM)-294.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.21%
Revenue 1Y (TTM)32.45%
Revenue growth 3Y68.95%
Revenue growth 5YN/A
Sales Q2Q%56.95%

3.2 Future

Based on estimates for the next years, ALESE will show a very strong growth in Earnings Per Share. The EPS will grow by 110.19% on average per year.
Based on estimates for the next years, ALESE will show a very strong growth in Revenue. The Revenue will grow by 38.17% on average per year.
EPS Next Y128.57%
EPS Next 2Y117.12%
EPS Next 3Y110.19%
EPS Next 5YN/A
Revenue Next Year38.3%
Revenue Next 2Y50.27%
Revenue Next 3Y51.15%
Revenue Next 5Y38.17%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALESE.PA Yearly Revenue VS EstimatesALESE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
ALESE.PA Yearly EPS VS EstimatesALESE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 0.4 0.6

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALESE. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 27.08, ALESE can be considered very expensive at the moment.
ALESE's Price/Forward Earnings ratio is rather expensive when compared to the industry. ALESE is more expensive than 81.82% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ALESE to the average of the S&P500 Index (36.12), we can say ALESE is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 27.08
ALESE.PA Price Earnings VS Forward Price EarningsALESE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALESE indicates a somewhat cheap valuation: ALESE is cheaper than 70.45% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.86
EV/EBITDA N/A
ALESE.PA Per share dataALESE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

ALESE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALESE's earnings are expected to grow with 110.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y117.12%
EPS Next 3Y110.19%

0

5. Dividend

5.1 Amount

ALESE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ENTECH SACA

EPA:ALESE (11/27/2025, 7:00:00 PM)

7.95

-0.06 (-0.75%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners11.38%
Inst Owner ChangeN/A
Ins Owners63.72%
Ins Owner ChangeN/A
Market Cap116.71M
Revenue(TTM)45.47M
Net Income(TTM)-2.92M
Analysts86
Price Target11.63 (46.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)50%
EPS NY rev (3m)500%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.93%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 27.08
P/S 2.57
P/FCF 8.86
P/OCF 8.23
P/B 4.52
P/tB 5.94
EV/EBITDA N/A
EPS(TTM)-0.2
EYN/A
EPS(NY)0.29
Fwd EY3.69%
FCF(TTM)0.9
FCFY11.29%
OCF(TTM)0.97
OCFY12.15%
SpS3.1
BVpS1.76
TBVpS1.34
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.88%
ROE -11.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.82%
FCFM 28.98%
ROA(3y)-2.34%
ROA(5y)-0.87%
ROE(3y)-4.85%
ROE(5y)-2.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.07%
GM growth 5YN/A
F-Score3
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 1.8
Debt/EBITDA N/A
Cap/Depr -3048.48%
Cap/Sales 2.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 1.51
Altman-Z 2.26
F-Score3
WACC7.68%
ROIC/WACCN/A
Cap/Depr(3y)285.26%
Cap/Depr(5y)212.15%
Cap/Sales(3y)7.1%
Cap/Sales(5y)9.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-294.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.21%
EPS Next Y128.57%
EPS Next 2Y117.12%
EPS Next 3Y110.19%
EPS Next 5YN/A
Revenue 1Y (TTM)32.45%
Revenue growth 3Y68.95%
Revenue growth 5YN/A
Sales Q2Q%56.95%
Revenue Next Year38.3%
Revenue Next 2Y50.27%
Revenue Next 3Y51.15%
Revenue Next 5Y38.17%
EBIT growth 1Y-189.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year308.6%
EBIT Next 3Y160.4%
EBIT Next 5Y103.56%
FCF growth 1Y230.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y258.99%
OCF growth 3YN/A
OCF growth 5YN/A

ENTECH SACA / ALESE.PA FAQ

What is the fundamental rating for ALESE stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALESE.PA.


Can you provide the valuation status for ENTECH SACA?

ChartMill assigns a valuation rating of 4 / 10 to ENTECH SACA (ALESE.PA). This can be considered as Fairly Valued.


What is the profitability of ALESE stock?

ENTECH SACA (ALESE.PA) has a profitability rating of 1 / 10.


Can you provide the financial health for ALESE stock?

The financial health rating of ENTECH SACA (ALESE.PA) is 6 / 10.